Doctors express concern over FDA scrutiny of RSV shots for babies

Doctors are worried about the FDA's scrutiny of RSV antibody shots, which are about 80% effective in preventing severe RSV in infants, while drugmakers maintain their safety.

25 Mar, 20:26 — 25 Mar, 20:26

Post Share

Sources

Showing 1 of 1 sources

NPRHigh2h ago

Doctors worry about FDA scrutiny of RSV shots to protect babies

The antibody shots are about 80% effective at preventing babies from ending up in intensive care because of RSV. The drugmakers behind them maintain they're safe.

Read full article →

PERSPECTA

PERSPECTA

Doctors express concern over FDA scrutiny of RSV shots for babies

Sources

Doctors worry about FDA scrutiny of RSV shots to protect babies

Related Stories

Police Report Tripled Suicide Cases in Metro Manila

Philippine National Police Issues Water Safety Guidelines

Guiuan, E. Samar Converts Evacuation Facility into Drug Rehab Center

Karlovy Vary Region Addresses Doctor Shortage with 'After Medicine Camp'

PERSPECTA